LINDA MACFARLANE: Open Payments
NPI 1073974564 · MANSFIELD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,669 in 18 payments from 14 companies in 2025. Trend: 2023 $2,447 · 2024 $1,733 · 2025 $1,669
Food & beverage: $1,352Education: $316
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $364 |
| Gilead Sciences, Inc. | 2 | $171 |
| Syndax Pharmaceuticals, Inc. | 1 | $139 |
| ABBVIE INC. | 1 | $125 |
| Pharmacosmos Therapeutics Inc. | 1 | $108 |
| Lilly USA, LLC | 1 | $108 |
| Merck Sharp & Dohme LLC | 1 | $104 |
| Eisai Inc. | 1 | $101 |
| Astellas Pharma US Inc | 1 | $99 |
| Janssen Biotech, Inc. | 1 | $92 |
Products named: Trodelvy, VENCLEXTA, MONOFERRIC, WELIREG, Lenvima, DARZALEX, BRUKINSA, OPDIVO.
Industry payments across OH — which companies pay providers there.
